To access the conference call within
|Conference call details:|
Neptune's Third Quarter Ended |
Management will accept questions related to the financial results and its operations by telephone during the Q&A period at the end of the presentation. Questions can also be forwarded in advance or during the presentation to email@example.com.
An archived recording of the conference call will be available on Neptune's website (www.neptunebiotech.com) shortly after the call.
Neptune's unaudited consolidated financial statements for the quarter ended
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids (''PUFAs''). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune's products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune's head office is located at 545 Promenade du Centropolis, Suite 1000,
Neptune respectively holdsapproximately 49.95% of the participating and voting rights of Acasti and 96% of the voting rights of
Forward Looking Statements
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements"within the meaning of the U.S. securities laws and Canadian securities laws. Suchforward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could causethe actual results of Neptune to be materially different from historical results or from any future results expressed orimplied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Neptune's public securities filings with the
"Neither NASDAQ nor the
Andre GodinChief Financial Officer +1.450.687.2262 firstname.lastname@example.org John RipplingerInvestor Relations +1.450.687.2262 email@example.com